SCHEMBL17084199

SCHEMBL17084199

CC(C)C(c1ccccc1)C(O)CN1CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A2 O15244 1/20 0.51
POLB P06746 2/20 0.48
ALDH1A1 P00352 4/20 0.47
HTT P42858 2/20 0.47
CYP2D6 P10635 1/20 0.47
TSHR P16473 1/20 0.47
HIF1A Q16665 1/20 0.47
MAOB P27338 1/20 0.47
GAA P10253 1/20 0.46
KDM4E B2RXH2 2/20 0.46
MITF O75030 1/20 0.46
RAB9A P51151 1/20 0.46
GFER P55789 1/20 0.46
PAX8 Q06710 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17084131 1.00 SLC22A2 (0.51) SLC22A2POLBALDH1A1HTTCYP2D6
Piperphenidol SCHEMBL29385617 0.85 SLC22A2 (0.56) SLC22A2ALDH1A1HTTKMT2ALTA4H
SCHEMBL11667975 0.80 MEN1 (0.56) POLBALDH1A1HTTCYP2D6TSHR
SCHEMBL3738538 0.80 MEN1 (0.56) POLBALDH1A1HTTCYP2D6TSHR
SCHEMBL9682618 0.79 GAA (0.50) POLBALDH1A1HTTGAAKDM4E
SCHEMBL7428017 0.78 CYP1A2 (0.54) POLBALDH1A1HTTCYP2D6TSHR
SCHEMBL4590361 0.77 HIF1A (0.49) POLBALDH1A1HTTCYP2D6TSHR
SCHEMBL17817490 0.77 ALDH1A1 (0.51) POLBALDH1A1HTTCYP2D6TSHR
SCHEMBL17084179 0.77 ALDH1A1 (0.50) POLBALDH1A1HTTHIF1AKDM4E
SCHEMBL8223804 0.76 GAA (0.69) ALDH1A1HTTCYP2D6TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9226922-B2 Compounds that are ERK inhibitors MERCK SHARP & DOHME CORP. (US) 2016-01-05 US disclosed
US-20150258074-A1 NOVEL COMPOUNDS THAT ARE ERK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150258074-A1 NOVEL COMPOUNDS THAT ARE ERK INHIBITORS MAPK1, MAPK4, MAP3K20 SLC22A2 3157/4885POLB 2222/4885ALDH1A1 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.